{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "R1441G, Y1699C, and G2019S variants in LRRK2 were associated with decreased phosphorylation levels and impaired 14-3-3 binding."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005303"
  },
  "Experiment Method": [
    {
      "Assay Method": "Affinity purification and mass spectrometry",
      "Material used": {
        "Material Source": "Mouse brain tissue",
        "Material Name": "N.D.",
        "Description": "Affinity purification was performed using mouse brain tissue to isolate LRRK2 and its interactors."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "Impaired 14-3-3 binding and reduced phosphorylation levels",
          "Molecular Effect": "Decreased phosphorylation of LRRK2 and disruption of 14-3-3 interaction",
          "Result Description": "The R1441G, Y1699C, and G2019S variants were shown to decrease phosphorylation levels of LRRK2 and impair its binding to 14-3-3 proteins."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal phosphorylation levels and intact 14-3-3 binding",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Reduced phosphorylation levels and impaired 14-3-3 binding",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Western blot",
      "Material used": {
        "Material Source": "Cell culture",
        "Material Name": "N.D.",
        "Description": "Western blot was performed to detect phosphorylation levels of LRRK2 using a specific antibody against pS935."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "Reduced phosphorylation levels",
          "Molecular Effect": "Decreased phosphorylation of LRRK2",
          "Result Description": "Western blot analysis confirmed reduced phosphorylation levels of LRRK2 in cells expressing the R1441G, Y1699C, and G2019S variants."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal phosphorylation levels (e.g., >80% of wild-type)",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Reduced phosphorylation levels (<50% of wild-type)",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}